Terms: = Colorectal cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
63 results:
1. Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US.
Paly VF; Dasari A; Hubbard J; Bekaii-Saab T; Padukkavidana T; Hernandez L
J Comp Eff Res; 2024 Aug; 13(8):e240084. PubMed ID: 38976346
[No Abstract] [Full Text] [Related]
2. A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma.
Song H; Li H; Shen X; Liu K; Feng H; Cui J; Wei W; Sun X; Fan Q; Bao W; Zhou H; Qian L; Nie H; Cheng X; Du Z
Acta Biomater; 2024 Mar; 177():456-471. PubMed ID: 38331131
[TBL] [Abstract] [Full Text] [Related]
3. Efficient Colon cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles.
Huang J; Wang K; Fu X; Zhu M; Chen X; Gao Y; Ma P; Duan X; Men K
Int J Nanomedicine; 2023; 18():8059-8075. PubMed ID: 38164262
[TBL] [Abstract] [Full Text] [Related]
4. Psoralea corylifolia formula extract-loaded silk fibroin/polycaprolactone fibrous membrane for the treatment of colorectal cancer.
Feng Y; Han Z; Chen C; Wang X; Liu J; Khan Y; Xie M; Chen Y; Zhang Y; Li G
Colloids Surf B Biointerfaces; 2024 Jan; 233():113635. PubMed ID: 37976725
[TBL] [Abstract] [Full Text] [Related]
5. Improved antitumor activity through a tyramidyl maslinic acid derivative. Design and validation as drug-loaded electrospun polymeric nanofibers.
Luque C; de la Cabeza Fernández M; Fuentes-Rios D; Cepero A; Contreras-Cáceres R; Doña M; Perazzoli G; Lozano-Chamizo L; Filice M; Marciello M; Gonzalez-Rumayor V; López-Romero JM; Cabeza L; Melguizo C; Prados J
Eur J Pharm Biopharm; 2023 Dec; 193():241-253. PubMed ID: 37972906
[TBL] [Abstract] [Full Text] [Related]
6. Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers.
Pouya FD; Salehi R; Rasmi Y; Kheradmand F; Fathi-Azarbayjani A
Life Sci; 2023 Nov; 332():122083. PubMed ID: 37717622
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of
Ejaz SA; Aziz M; Fawzy Ramadan M; Fayyaz A; Bilal MS
Molecules; 2023 May; 28(10):. PubMed ID: 37241785
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
9. Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-pcl hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.
Shahidi S; Rostamizadeh K; Fathi M; Nedaei K; Ramazani A
BMC Complement Med Ther; 2022 Dec; 22(1):340. PubMed ID: 36575448
[TBL] [Abstract] [Full Text] [Related]
10. Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p/vegfr3/AKT axis to ameliorate inflammatory bowel disease.
Zhang L; Yuan J; Kofi Wiredu Ocansey D; Lu B; Wan A; Chen X; Zhang X; Qiu W; Mao F
Int Immunopharmacol; 2022 Sep; 110():109066. PubMed ID: 35978512
[TBL] [Abstract] [Full Text] [Related]
11. [A prospective cohort study on the clinical value of pelvic peritoneal reconstruction in laparoscopic anterior resection for middle and low rectal cancer].
Ji LQ; Lou Z; Gong HF; Sui JK; Cao FA; Yu GY; Zhu XM; Zheng NX; Meng RG; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):336-341. PubMed ID: 35461202
[No Abstract] [Full Text] [Related]
12. Preparing Future Medicine Physicians to Care for cancer Survivors: Project ECHO® in a Novel Internal Medicine and Family Medicine Residency Curriculum.
Choi Y; Chodoff AC; Brown K; Murillo LA; Nesfeder J; Bugayong MT; Peairs KS
J Cancer Educ; 2023 Apr; 38(2):608-617. PubMed ID: 35366218
[TBL] [Abstract] [Full Text] [Related]
13. Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
Mehta R; Frakes J; Kim J; Nixon A; Liu Y; Howard L; Martinez Jimenez ME; Carballido E; Imanirad I; Sanchez J; Dessureault S; Xie H; Felder S; Sahin I; Hoffe S; Malafa M; Kim R
Oncologist; 2022 Aug; 27(8):621-e617. PubMed ID: 35325225
[TBL] [Abstract] [Full Text] [Related]
14. Plasma Protein Biomarkers in Advanced or Metastatic colorectal cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).
Nixon AB; Sibley AB; Liu Y; Hatch AJ; Jiang C; Mulkey F; Starr MD; Brady JC; Niedzwiecki D; Venook AP; Baez-Diaz L; Lenz HJ; O'Neil BH; Innocenti F; Meyerhardt JA; O'Reilly EM; Owzar K; Hurwitz HI
Clin Cancer Res; 2022 Jul; 28(13):2779-2788. PubMed ID: 34965954
[TBL] [Abstract] [Full Text] [Related]
15. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient cancer Immunogene Therapy.
Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H
Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545
[TBL] [Abstract] [Full Text] [Related]
16. Polymeric Nanovectors Incorporated with Ganciclovir and HSV-
Sawdon AJ; Zhang J; Peng S; Alyami EM; Peng CA
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801024
[TBL] [Abstract] [Full Text] [Related]
17. Changes in Incidence and Survival by Decade of Patients With Primary colorectal Lymphoma: A SEER Analysis.
Li Q; Mo S; Dai W; Li Y; Xu Y; Li X; Cai G; Cai S
Front Public Health; 2020; 8():486401. PubMed ID: 33178655
[No Abstract] [Full Text] [Related]
18. Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
Salimifard S; Karoon Kiani F; Sadat Eshaghi F; Izadi S; Shahdadnejad K; Masjedi A; Heydari M; Ahmadi A; Hojjat-Farsangi M; Hassannia H; Mohammadi H; Boroumand-Noughabi S; Keramati MR; Jadidi-Niaragh F
Life Sci; 2020 Nov; 260():118423. PubMed ID: 32941896
[TBL] [Abstract] [Full Text] [Related]
19. Co-Culturing of Endothelial and cancer Cells in a Nanofibrous Scaffold-Based Two-Layer System.
Oh YS; Choi MH; Shin JI; Maza PAMA; Kwak JY
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531897
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis of combinatorial Janus nanoparticles based on EpCAM-PEG/pcl for targeted therapy of human colorectal adenocarcinoma.
Khezrian S; Khoee S; Caceres M
J Biomed Mater Res A; 2020 Nov; 108(11):2291-2304. PubMed ID: 32363740
[TBL] [Abstract] [Full Text] [Related]
[Next]
